Neo-Sequence 2：NCT Plus Anti-angiogenesis Therapy and Immunotherapy for LADGC
Clinical trial NCT06371586 · RECRUITING
Trial details
- NCT number
- NCT06371586
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-01
- Primary completion
- 2027-03-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.